AACR Annual Meeting 2018: Off-the-shelf CAR T-cell Immunotherapy – Are we There Yet?

A study presented at the AACR Annual Meeting 2018 discussed preliminary data on an off-the-shelf, T-cell receptor (TCR)-less, dual-targeted CD19-CAR T-cell product, FT819. In proof-of-concept preclinical studies, FT819 was found …

Read More

Highlighting Pediatric Preclinical Drug Testing at the Annual Meeting 2018

The AACR’s Pediatric Cancer Working Group, which now boasts over 2,500 members, will hold a special scientific session at the Annual Meeting, where ongoing advances and existing challenges in cancer research will be discussed through the pediatric lens.

Read More

Early-career Researchers Share Their Passions on Capitol Hill

US Capitol Building

Each year, the American Association for Cancer Research (AACR) is proud to bring Associate Members to Washington, D.C., where they meet with legislators and policymakers to discuss issues that are critical to supporting medical research.

Read More